Mineralys Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Mineralys Therapeutics's estimated annual revenue is currently $5.7M per year.
- Mineralys Therapeutics's estimated revenue per employee is $77,500
- Mineralys Therapeutics's total funding is $158M.
Employee Data
- Mineralys Therapeutics has 73 Employees.
- Mineralys Therapeutics grew their employee count by 40% last year.
Mineralys Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP Medical Affairs | Reveal Email/Phone |
3 | VP Clinical Research | Reveal Email/Phone |
4 | SVP Finance & Controller | Reveal Email/Phone |
5 | VP, Human Resources | Reveal Email/Phone |
6 | VP Clinical Development | Reveal Email/Phone |
7 | VP, Clinical Pharmacology | Reveal Email/Phone |
8 | SVP Quality Assurance | Reveal Email/Phone |
9 | SVP, Clinical Operations | Reveal Email/Phone |
10 | SVP, CMC | Reveal Email/Phone |
Mineralys Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $1.4M | 9 | -10% | N/A | N/A |
#2 | $7.1M | 46 | 77% | N/A | N/A |
#3 | $14.4M | 93 | 27% | N/A | N/A |
#4 | $0.9M | 6 | 0% | N/A | N/A |
#5 | $1.6M | 10 | 43% | N/A | N/A |
#6 | $11.5M | 74 | 6% | N/A | N/A |
#7 | $0.9M | 11 | 22% | N/A | N/A |
#8 | $3.7M | 24 | -8% | N/A | N/A |
#9 | $2M | 13 | 18% | N/A | N/A |
#10 | $9.3M | 60 | 2% | N/A | N/A |
What Is Mineralys Therapeutics?
At Mineralys Therapeutics we aim to redefine hypertension diagnosis, management and treatment. We are driven to break the “trial and failure” approach to hypertension management and bring a personalized approach to the management of hypertension.
keywords:N/A$158M
Total Funding
73
Number of Employees
$5.7M
Revenue (est)
40%
Employee Growth %
N/A
Valuation
N/A
Accelerator
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $15.3M | 76 | -48% | N/A |
#2 | $16.2M | 116 | 16% | N/A |
#3 | $17.6M | 126 | 15% | $58.7M |
#4 | $18.2M | 130 | -4% | N/A |
#5 | $29.7M | 135 | 52% | N/A |
